Literature DB >> 20335529

CXC chemokine ligand 4 induces a unique transcriptome in monocyte-derived macrophages.

Christian A Gleissner1, Iftach Shaked, Kristina M Little, Klaus Ley.   

Abstract

In atherosclerotic arteries, blood monocytes differentiate to macrophages in the presence of growth factors, such as macrophage colony-stimulation factor (M-CSF), and chemokines, such as platelet factor 4 (CXCL4). To compare the gene expression signature of CXCL4-induced macrophages with M-CSF-induced macrophages or macrophages polarized with IFN-gamma/LPS (M1) or IL-4 (M2), we cultured primary human peripheral blood monocytes for 6 d. mRNA expression was measured by Affymetrix gene chips, and differences were analyzed by local pooled error test, profile of complex functionality, and gene set enrichment analysis. Three hundred seventy-five genes were differentially expressed between M-CSF- and CXCL4-induced macrophages; 206 of them overexpressed in CXCL4 macrophages coding for genes implicated in the inflammatory/immune response, Ag processing and presentation, and lipid metabolism. CXCL4-induced macrophages overexpressed some M1 and M2 genes and the corresponding cytokines at the protein level; however, their transcriptome clustered with neither M1 nor M2 transcriptomes. They almost completely lost the ability to phagocytose zymosan beads. Genes linked to atherosclerosis were not consistently upregulated or downregulated. Scavenger receptors showed lower and cholesterol efflux transporters showed higher expression in CXCL4- than M-CSF-induced macrophages, resulting in lower low-density lipoprotein content. We conclude that CXCL4 induces a unique macrophage transcriptome distinct from known macrophage types, defining a new macrophage differentiation that we propose to call M4.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20335529      PMCID: PMC3418140          DOI: 10.4049/jimmunol.0901368

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  35 in total

1.  Platelet factor 4 (CXC chemokine ligand 4) differentially regulates respiratory burst, survival, and cytokine expression of human monocytes by using distinct signaling pathways.

Authors:  Brigitte Kasper; Ernst Brandt; Sven Brandau; Frank Petersen
Journal:  J Immunol       Date:  2007-08-15       Impact factor: 5.422

Review 2.  Monocyte and macrophage heterogeneity.

Authors:  Siamon Gordon; Philip R Taylor
Journal:  Nat Rev Immunol       Date:  2005-12       Impact factor: 53.106

3.  Macrophage heterogeneity and tissue lipids.

Authors:  Siamon Gordon
Journal:  J Clin Invest       Date:  2007-01       Impact factor: 14.808

Review 4.  Macrophage activation and polarization.

Authors:  Fernando Oneissi Martinez; Antonio Sica; Alberto Mantovani; Massimo Locati
Journal:  Front Biosci       Date:  2008-01-01

Review 5.  The macrophage: past, present and future.

Authors:  Siamon Gordon
Journal:  Eur J Immunol       Date:  2007-11       Impact factor: 5.532

6.  PPARgamma activation primes human monocytes into alternative M2 macrophages with anti-inflammatory properties.

Authors:  M Amine Bouhlel; Bruno Derudas; Elena Rigamonti; Rébecca Dièvart; John Brozek; Stéphan Haulon; Christophe Zawadzki; Brigitte Jude; Gérard Torpier; Nikolaus Marx; Bart Staels; Giulia Chinetti-Gbaguidi
Journal:  Cell Metab       Date:  2007-08       Impact factor: 27.287

7.  CXCL4 in atherosclerosis: possible roles in monocyte arrest and macrophage foam cell formation.

Authors:  Christian A Gleissner; Klaus Ley
Journal:  Thromb Haemost       Date:  2007-11       Impact factor: 5.249

8.  Induction of dendritic cell-like phenotype in macrophages during foam cell formation.

Authors:  Hyung Jun Cho; Pavel Shashkin; Christian A Gleissner; Dane Dunson; Nitin Jain; Jae K Lee; Yury Miller; Klaus Ley
Journal:  Physiol Genomics       Date:  2007-01-23       Impact factor: 3.107

9.  Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles.

Authors:  Aravind Subramanian; Pablo Tamayo; Vamsi K Mootha; Sayan Mukherjee; Benjamin L Ebert; Michael A Gillette; Amanda Paulovich; Scott L Pomeroy; Todd R Golub; Eric S Lander; Jill P Mesirov
Journal:  Proc Natl Acad Sci U S A       Date:  2005-09-30       Impact factor: 11.205

10.  Elimination of platelet factor 4 (PF4) from platelets reduces atherosclerosis in C57Bl/6 and apoE-/- mice.

Authors:  Bruce S Sachais; Tiffany Turrentine; Jennine M Dawicki McKenna; Ann H Rux; Daniel Rader; M Anna Kowalska
Journal:  Thromb Haemost       Date:  2007-11       Impact factor: 5.249

View more
  97 in total

Review 1.  Macrophage subsets in atherosclerosis.

Authors:  Giulia Chinetti-Gbaguidi; Sophie Colin; Bart Staels
Journal:  Nat Rev Cardiol       Date:  2014-11-04       Impact factor: 32.419

Review 2.  Macrophage plasticity and interaction with lymphocyte subsets: cancer as a paradigm.

Authors:  Subhra K Biswas; Alberto Mantovani
Journal:  Nat Immunol       Date:  2010-09-20       Impact factor: 25.606

3.  Platelet-macrophage partnership in innate immunity and inflammation.

Authors:  Alberto Mantovani; Cecilia Garlanda
Journal:  Nat Immunol       Date:  2013-08       Impact factor: 25.606

Review 4.  Platelets: versatile effector cells in hemostasis, inflammation, and the immune continuum.

Authors:  Adriana Vieira-de-Abreu; Robert A Campbell; Andrew S Weyrich; Guy A Zimmerman
Journal:  Semin Immunopathol       Date:  2011-08-06       Impact factor: 9.623

Review 5.  Macrophage polarization in metabolic disorders: functions and regulation.

Authors:  Giulia Chinetti-Gbaguidi; Bart Staels
Journal:  Curr Opin Lipidol       Date:  2011-10       Impact factor: 4.776

6.  IL-17A influences essential functions of the monocyte/macrophage lineage and is involved in advanced murine and human atherosclerosis.

Authors:  Christian Erbel; Mohammadreza Akhavanpoor; Deniz Okuyucu; Susanne Wangler; Alex Dietz; Li Zhao; Konstantinos Stellos; Kristina M Little; Felix Lasitschka; Andreas Doesch; Maani Hakimi; Thomas J Dengler; Thomas Giese; Erwin Blessing; Hugo A Katus; Christian A Gleissner
Journal:  J Immunol       Date:  2014-09-26       Impact factor: 5.422

7.  Pivotal role of NOD2 in inflammatory processes affecting atherosclerosis and periodontal bone loss.

Authors:  Huaiping Yuan; Sami Zelkha; Sami Zelka; Marina Burkatovskaya; Rohit Gupte; Susan E Leeman; Salomon Amar
Journal:  Proc Natl Acad Sci U S A       Date:  2013-12-09       Impact factor: 11.205

Review 8.  Inflammation and immune system interactions in atherosclerosis.

Authors:  Bart Legein; Lieve Temmerman; Erik A L Biessen; Esther Lutgens
Journal:  Cell Mol Life Sci       Date:  2013-02-21       Impact factor: 9.261

Review 9.  Making a difference: monocyte heterogeneity in cardiovascular disease.

Authors:  Ingo Hilgendorf; Filip K Swirski
Journal:  Curr Atheroscler Rep       Date:  2012-10       Impact factor: 5.113

Review 10.  Mechanisms of antibody-mediated acute and chronic rejection of kidney allografts.

Authors:  William M Baldwin; Anna Valujskikh; Robert L Fairchild
Journal:  Curr Opin Organ Transplant       Date:  2016-02       Impact factor: 2.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.